Biocare Medical, LLC, a leading provider of innovative, automated immunohistochemistry (IHC) instrumentation and reagents, announces the release of the VALENT IVD (in vitro diagnostic) automated staining platform.
VALENT is the industry’s first fully automated, open platform, merging high-throughput and quality staining with a powerful and intuitive user interface. VALENT overcomes the limitations of closed systems with its unique open platform, allowing reagents from multiple sources and providing top-tier IHC results. VALENT transforms clinical, pharmaceutical and research laboratories by providing an easy-to-use fully automated platform, 48-slide capacity, multiplex IHC capability, and high-quality staining.
“We work closely with customers, in all different testing environments, to maintain a deep understanding of their job demands and requirements,” said Morgan Porter, Chief Operating Officer of Biocare Medical. “That’s why we’re so thrilled to introduce the VALENT to the market and provide our customers with the most innovative staining platform available in the industry today.”
“The on-line HIER feature of Biocare’s VALENT enables walkaway freedom for the histotech,” said Cheryl Bodden, Histology Laboratory Manager at USF Health Labs.